about
Treatment for small cell lung cancer, where are we now?-a reviewAmrubicin for relapsed small-cell lung cancer: a systematic review and meta-analysis of 803 patientsElevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer CellsCombining immunotherapy and radiation therapy for small cell lung cancer and thymic tumorsQuantitative proteomics in lung cancer.Temporal trends from 1986 to 2008 in overall survival of small cell lung cancer patients.MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells.Early screening of lung cancers: an effort arduous but worthwhileTargeted therapy for non-small cell lung cancer: current standards and the promise of the future.Metal complexes in cancer therapy - an update from drug design perspective.Apoptosis of Lewis Lung Carcinoma Cells Induced by Microwave via p53 and Proapoptotic Proteins In vivo.Alkylating Agent-Induced NRF2 Blocks Endoplasmic Reticulum Stress-Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis.Synergistic killing of human small cell lung cancer cells by the Bcl-2-inositol 1,4,5-trisphosphate receptor disruptor BIRD-2 and the BH3-mimetic ABT-263.The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.What's New in SCLC? A Review.Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse.A study on different therapies and prognosis-related factors for 101 patients with SCLC and brain metastases.[Multicenter Evaluation of A New Progastrin-releasing Peptide (ProGRP) Immunoassay across Europe and China].Drug Combination Synergy in Worm-like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer.Targeting DNA damage repair in small cell lung cancer and the biomarker landscape.[Advances in the Treatment of Relapsed Small Cell Lung Cancer].The evolving role of radiotherapy in the management of small cell lung cancer
P2860
Q26767023-EBC7CD41-68A6-4841-BA3B-C4F7B157AE0EQ28072672-FEEC150E-844C-4DBB-855F-C432DFB85B20Q28553961-92488B89-75D6-4C37-A2E3-0DB048C5D581Q33645601-8497E934-EF33-4150-BDAA-D7E423AD99F2Q33796358-3A9EE9EF-2223-4A91-B355-A6C405E94D77Q34226656-AB93A3E6-35B6-45A4-A5B2-63BCC3B0F8BFQ34733320-E17544BD-AA17-47EA-B850-003651B5F086Q36184617-DE57CE9D-30F8-4E2B-A1A3-A222C07269CEQ36419125-81AD232B-96F8-41AD-AF40-E0E19002067FQ38390200-8A009250-F9AB-4416-B345-038F36B31861Q38692975-7FB3E746-3DEE-4BB9-B99A-AE70BE3181A0Q38723069-D8FD8B6D-1406-46BD-BD27-1C132D6D14AEQ38745839-32CC1907-646C-4271-B064-E5C4A7456E14Q38807526-55CDE691-2884-4FF2-B5E2-C4481D2ADC11Q38847321-D343B14A-DEC9-494E-9E59-6CDE256B6308Q40049841-98E79DD9-045E-40E6-9026-5DA0C987BC95Q47140422-496BC09E-051B-45BF-8BEE-54F1496E7ACAQ47630582-A5D0178D-4015-4E33-A2A6-76DC45FCB75DQ48152616-26B613C9-2694-4B78-BB6E-FBA4AB50A699Q50268805-A88376D4-3920-46E8-BFA7-88FA63281A31Q51734368-052112D1-8CE0-471D-8695-35BD88F8FAADQ52657032-F9AB8223-87E0-431E-82C3-AF0E487AE3CCQ53747313-5D861F9E-83FE-4143-875E-5ABB13034E41Q58804836-AF53FD1B-B2DE-4376-8A56-4448500EF618
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Chemotherapy advances in small-cell lung cancer
@en
type
label
Chemotherapy advances in small-cell lung cancer
@en
prefLabel
Chemotherapy advances in small-cell lung cancer
@en
P2860
P1476
Chemotherapy advances in small-cell lung cancer
@en
P2093
Bryan A Chan
P2860
P304
P356
10.3978/J.ISSN.2072-1439.2013.07.43
P478
P577
2013-10-01T00:00:00Z